In individuals with mild to moderate COVID-19 symptoms, an antibody cocktail is believed to lower the likelihood of hospitalisation by 70%. Here's all you need to know about the treatment.
While advocating rational use of the Covid-19 monoclonal antibody cocktail, former ICMR scientist Dr Raman Gangakhedkar said the treatment is unlikely to result in further mutations of the virus.
Antibody cocktail is said to reduce the chance of hospitalisation by 70 per cent in patients with mild to moderate Covid-19 symptoms. Here is all you need to know about the therapy